1 / 6

Clinical Trial Design, Biostatistics, Ethics, and Recruitment

Clinical Trial Design, Biostatistics, Ethics, and Recruitment. Clinical Trial Design Anthony J. Murgo, MD.,MS; NCI/DCTD Biostatistics Larry Rubinstein, PhD; NCI/DCTD/BRB Ethical Considerations Holly Taylor, PhD,MPH; JHU Berman Bioethics Instit. David Wendler, PhD; NIH Clinical Center

thortone
Télécharger la présentation

Clinical Trial Design, Biostatistics, Ethics, and Recruitment

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Clinical Trial Design, Biostatistics, Ethics, and Recruitment Clinical Trial Design • Anthony J. Murgo, MD.,MS; NCI/DCTD Biostatistics • Larry Rubinstein, PhD; NCI/DCTD/BRB Ethical Considerations • Holly Taylor, PhD,MPH; JHU Berman Bioethics Instit. • David Wendler, PhD; NIH Clinical Center Phase 0 and patients • Deborah Collyar; Pres. Patient Advocates In Research Recruitment • Martin Gutierrez, MD; NCI/CCR

  2. Phase 0 Trial DesignsHow do They Differ From First-in-Human Phase 1 Trials Anthony J. Murgo, MD, MS Division of Cancer Treatment and Diagnosis National Cancer Institute Building 10, Warren Grant Magnuson Clinical Center Mark O. Hatfield Clinical Research Center Sept. 5, 2007

  3. Differences Between Phase 0 & Phase 1 Trials

  4. Differences Between Phase 0 & Phase 1 Trials

  5. Differences Between Phase 0 & Phase 1 Trials

  6. The Next Speaker is:Dr. Larry Rubinstein

More Related